biotech
UCSF Recruits Smokers For NicVax Trials
Filed in archive Drugs, Vaccines and Therapeutics by ruth on June 13, 2006
UCSF Recruits Smokers For NicVax Trials
Earlier this year, Nabi Pharmaceuticals' NicVax received a fast-track designation by the Food and Drug Administration to speed up the development of the investigational vaccine against nicotine addiction. NicVax acts by binding to and preventing the entry of nicotine into the brain, thereby reducing the addictive effects of smoking.

The University of California San Francisco's Habit Abatement Clinic is now recruiting smokers to determine whether the vaccine can help people quit smoking and avoid a relapse within 12 months. Participation in the study requires a one-year commitment. The study will be sponsored by Nabi Pharmaceuticals and the National Institute on Drug Abuse.


Permalink: UCSF Recruits Smokers For NicVax Trials
Tags: smoking  vaccine  biotech  nicvax  smokers  ucsf+recruits  nicvax+trials  smokers+nicvax 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/24518
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for UCSF Recruits Smokers For NicVax Trials:

  • Currently 9.50/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 9.50 out of 4 vote(s) cast.
 
Subscribe
Share It
Popular posts from our other blogs:
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!